Key Highlights continued

Similar documents
Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2017

Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016

Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment

Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission

INTERNATIONAL ASSISTANCE FOR HIV/AIDS IN THE DEVELOPING WORLD: TAKING STOCK OF

Monitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators

Overview of development assistance for health trends

Post-2015: Innovative Financing of HIV/AIDS. Travis Mitchell Economic Affairs Division

Overview of development assistance for health trends

Global Funding for HIV/AIDS in Resource Poor Settings

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

CRS Report for Congress

Okinawa, Toyako, and Beyond: Progress on Health and Development

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

OUTLOOK EXAMINES MAKING SENSE OF THE MONEY + WHERE DOES THE MONEY FOR AIDS GO?

RESOURCE NEEDS FOR AN EXPANDED RESPONSE TO AIDS IN LOW AND MIDDLE INCOME COUNTRIES. Presented at the Programme Coordinating Board

GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW

Development assistance for HIV/AIDS, tuberculosis and malaria by channel

Filling the Funding Gap to Save Lives

This brief analyses investments by OECD Development Assistance Committee (DAC) donors in six policy areas

The U.S. President s Emergency Plan for AIDS Relief (PEPFAR)

U.S. Funding for International Family Planning & Reproductive Health

AIDS Funding Landscape in Asia and the Pacific

The health economic landscape of cancer in Europe

Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011

Drug Money: the illicit proceeds of opiates trafficked on the Balkan route. Executive summary

Type 1 Diabetes Australian Research Impact Analysis

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

TOBACCO CONTROL ECONOMICS TOBACCO FREE INITIATIVE PREVENTION OF NONCOMMUNICABLE DISEASES

HAS DONOR PRIORITIZATION OF HIV/AIDS CONTROL DISPLACED AID FOR OTHER HEALTH CAUSES?

IMPACT OF DEVELOPMENT ASSISTANCE FOR HEALTH ON COUNTRY SPENDING

The power of innovation to save lives

Donor contributions and commitments as of April 2011

Innovative Finance: the power of innovation to save lives

CRS Report for Congress

Latest Funding Trends in AIDS Response

Case study examining the impact of German reunification on life expectancy

Renewing Momentum in the fight against HIV/AIDS

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

This technical paper analyses investments by OECD Development Assistance Committee (DAC) donors in six

Survey of G7 Nations on HIV Spending in Developing Countries

2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

IARC A UNIQUE AGENCY. Cancer research for cancer prevention

REPORT FROM THE COMMISSION. Annual Report ( )

NBER WORKING PAPER SERIES ALCOHOL CONSUMPTION AND TAX DIFFERENTIALS BETWEEN BEER, WINE AND SPIRITS. Working Paper No. 3200

MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division

1. The World Bank-GAVI Partnership and the Purpose of the Review

GLP in the European Union Ecolabel detergents, GLP and accreditation

The Global Fund & UNICEF Partnership

39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016

National Aids Spending Assessment Report

Q Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures

TRANSITIONING FROM DONOR SUPPORT FOR TB & HIV IN EUROPE

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

An analysis of structural changes in the consumption patterns of beer, wine and spirits applying an alternative methodology

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

1. Global Fund on HIV/AIDS, Tuberculosis and Malaria

TRACKING FUNDING FOR MICROBICIDE RESEARCH & DEVELOPMENT:

CHARTING THE COURSE FOR CANADA S NATIONAL DEMENTIA STRATEGY PRE-BUDGET SUBMISSION TO THE HOUSE OF COMMONS STANDING COMMITTEE ON FINANCE

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

The road towards universal access

10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan,

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019

(Please check against delivery) EMBARGOED FOR 20 APRIL 2017 AT 0900 EST/1500 CET. Ladies and gentlemen,

Global Fund experience on financing the fight against AIDS, tuberculosis and malaria History and lessons learnt Hearings at WHO GCM/NCD working group

Working for an International Organization in Public-Private Partnership : The Global Fund to Fight AIDS, Tuberculosis and Malaria

Joint Programming in Neurodegenerative Disease Research (JPND)

COMMISSION OF THE EUROPEAN COMMUNITIES

1. Global Fund on HIV/AIDS, Tuberculosis and Malaria [31]

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

FORUM FOR AEROSPACE NDT BOARDS

FAO of the UN, WHO and OIE with the collaboration of UNSIC and UNICEF. Background Paper

The Millennium Development Goals. A Snapshot. Prepared by DESA based on its annual Millennium Development Goals Report

VARIATIONS IN PRICES AND REIMBURSEMENT OF MEDICINES IN THE EUROPEAN UNION

AIDS by the Numbers: Where Do We Stand with ? Peter Ghys, UNAIDS

PROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name

NEGLECTED DISEASE FUNDERS

AUGUST 200 JULY Reauthorization of PEPFAR, The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act:

Drug Consumption Rooms Worldwide

STRATEGIC APPROACH & WORKPLAN 2007

ECDC s role in the fight against HIV/AIDS in Europe

Ex Post-Evaluation Brief ETHIOPIA: Family Planning and HIV Prevention I and II

Presentation by Dr Philippe Douste-Blazy. Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development

Key Messages for World Malaria Day 2009

Suraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director. On behalf of the Tuberculosis Roundtable

European status report on alcohol and health Leadership, awareness and commitment

State of provision of Hearing Aids in Europe

UNICEF AND MALARIA MEDICINES. Supply Division October 2006

UK bowel cancer care outcomes: A comparison with Europe

Place matters: why cities are key to ending AIDS

Transcription:

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009 Authors: Jennifer Kates (Kaiser Family Foundation), Kim Boortz (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS), Benjamin Gobet (UNAIDS). July 2010

Introduction Financing a sufficient and sustained response to the HIV epidemic in low- and middle- income countries has emerged as one of the world s greatest health and development challenges, and one that will be with us for the foreseeable future. International assistance from donor governments, through bilateral aid and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and other financing channels such as UNITAID (the international drug purchase facility) is a critical part of this response. Other funding sources include multilateral institutions, the private sector, and domestic spending by many affected-country governments and the households and individuals within them. Although funding from all these sources has risen significantly over the past decade, the gap between UNAIDS estimate of resources needed to combat the HIV epidemic and resources available was approximately $7.7 billion in 2009, up from a $6.5 billion gap in 2008. Moreover, after years of funding increases for AIDS from donor governments, this report finds that funding was essentially flat between 2008 and 2009. While this finding generally mirrors the larger trend in overall official development assistance over the same period, and is in part due to exchange rate fluctuations, it also reflects real decreases among some donors, and raises concerns about the ability to fill the AIDS funding gap going forward. Tracking donor funding to combat the epidemic, therefore, is critical. Each year, UNAIDS and the Kaiser Family Foundation collect and analyze data to document international assistance for AIDS in low- and middle- income countries. This latest report provides data from 2009, the most recent year available. As such, it represents funding levels reflecting budgeting decisions that occurred during the current global economic crisis. The analysis is based on data provided by governments -- including the Group of Eight (G8), Australia, Denmark, Ireland, The Netherlands, Norway, Spain, Sweden, and other donor government members of the Organisation for Economic Co-operation and Development (OECD) s Development Assistance Committee (DAC) -- as well as from the European Commission (EC). It includes bilateral assistance and contributions to the Global Fund and UNITAID. Data were collected and analyzed as part of a collaborative effort between UNAIDS and the Kaiser Family Foundation, with research assistance provided by the Stimson Center. 1

Key Highlights After years of significant increases for international AIDS assistance provided by the G8, EC, and other donor governments, funding remained essentially flat over the 2008-2009 period: Disbursements (actual resources available in a given year) were US$7.6 billion in 2009, compared to $7.7 billion in 2008 (see Chart 4). The observed decrease in disbursements between 2008 and 2009 is difficult to interpret due to currency fluctuations and reporting cycles. Identified new commitments (enacted amounts by governments, not all of which are necessarily disbursed in a given year) totalled US$8.7 billion, the same as in 2008 (see Chart 4). Level funding for the AIDS response between 2008 and 2009, follows years of significant increases: disbursements to combat the epidemic rose more than six-fold between 2002 and 2008 (see Chart 4). In 2009, funding provided to the Global Fund totalled US$2.7 billion in 2009, of which US$1.6 billion represents an adjusted AIDS share (see Chart 7). Funding for UNITAID totalled $250 million, of which $123 million represents an adjusted AIDS share. A subset of G8 Members and, notably, a few non-g8 Members, account for the majority of international AIDS assistance from donor governments: In 2009, the United States was the largest donor in the world, accounting for more than half (58.0%) of disbursements by governments. In fact, without U.S. funding, international AIDS assistance from donor governments would have significantly declined between 2008 and 2009. The United Kingdom accounted for the second largest share of disbursements in 2009 (10.2%), followed by Germany (5.2%), the Netherlands (5.0%), and France (4.4%). Denmark accounted for 2.5% (see Chart 5). After adjusting for exchange rate fluctuations, real changes in international AIDS assistance were observed among some donors between 2008 and 2009. Funding provided by the U.S., Sweden, and the European Commission increased in real terms, while funding from Canada, France, Germany, Ireland, Italy, and the Netherlands decreased; funding provided by Australia, Japan, and Norway was essentially flat. Further analysis is required to assess the extent to which changes in funding provided by the UK were the result of currency exchange rates or other factors. 2

Key Highlights continued Most international assistance to combat the epidemic is provided bilaterally, although funding channels vary by donor: Bilateral assistance as identified for purposes of this analysis (which includes funding earmarked for AIDS through multilateral instruments, such as UNAIDS), accounted for 77% of disbursements in 2009; the remainder was provided multilaterally through the Global Fund and UNITAID. Funding channel patterns vary significantly by donor (see Chart 8). Other international financing sources -- not documented in this report -- include multilateral institutions such as U.N. agencies, multilateral development banks such as the World Bank, and the private sector. UNAIDS estimates that US$23.6 billion was needed to address the epidemic in low- and middle- income countries in 2009: Of this, an estimated US$15.9 billion was available from all sources (public and private), with bilateral international assistance accounting for 37% (US$5.9 billion in disbursements). The U.S., U.K., and the Netherlands accounted for the largest shares of such assistance funding. Still, there was a gap of US$7.7 billion between resources available from all sources and resources needed in 2009, as estimated by UNAIDS (see Chart 9). Assessing fair share in the context of international assistance is complex and there is no single, agreed upon methodology for doing so. Two different methodologies used in this analysis indicate that, in 2009: The U.S. provided 27% of the funding available for AIDS from all sources (donor governments, multilaterals, the private sector, and domestic sources), the largest share of any donor and just below its share of the world s economy as measured by gross domestic product or GDP (25% in 2009). The U.K. and the Netherlands each provided greater shares of total AIDS resources than their shares of GDP (see Chart 10). When standardized by GDP per US$1 million, to account for differences in the sizes of government economies, Denmark provided the highest amount of resources for AIDS in 2009, followed by the Netherlands, Sweden, the United Kingdom, and Ireland (see Chart 11). 3

International AIDS Assistance: Trends in G8/EC & Other Donor Government Assistance, 2002-2009 USD billions $8.7 $8.7 $7.7 $7.6 $3.6 $4.3 $5.6 $6.6 $2.8 $3.5 $3.9 $4.9 $1.6 $2.0 $1.2 $1.6 2002 2003 2004 2005 2006 2007 2008 2009 2002 2003 2004 2005 2006 2007 2008 2009 Commitments (Enacted Amounts) Disbursements Sources: UNAIDS and Kaiser Family Foundation analyses; Global Fund to Fight AIDS, Tuberculosis and Malaria online data queries; UNITAID Annual Report, 2009; OECD CRS online data queries; UNAIDS, PCB(13)/02.5, 28 November 2002; UNAIDS, PCB(14)/03 Conference Paper 2a, 25 June 2003. Notes: Bilateral funding includes HIV-earmarked multilateral funding but does not include the Global Fund or UNITAID. Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (49.1% for HIV). Data from 2002 and 2003 do not include Global Fund contributions. See Methodology for additional detail. 4

International AIDS Assistance: G8/EC & Other Donor Governments as Share of Total Disbursements, 2009 USD billions Germany 5.2% Netherlands 5.0% France 4.4% Denmark 2.5% Sweden 2.2% Spain 2.1% Japan 1.9% Norway 1.7% Canada 1.7% United Kingdom 10.2% EC 1.5% Ireland 1.1% Australia 1.3% United States 58.0% Italy 0.1% Other Govts 1.0% $7.6 billion Total Disbursements Sources: UNAIDS and Kaiser Family Foundation analysis, July 2010; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query, June 2010; UNITAID Annual Report, 2009; OECD CRS online data queries; UNAIDS, PCB(13)/02.5, 28 November 2002; UNAIDS, PCB(14)/03 Conference Paper 2a, 25 June 2003. Notes: Bilateral funding includes HIV-earmarked multilateral funding but does not include the Global Fund or UNITAID; Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (49.1% for HIV). Data from 2002 and 2003 do not include Global Fund contributions. See Methodology for additional detail. 5

International AIDS Assistance: G8/EC & Other Donor Governments as Share of Bilateral Disbursements, 2009 USD billions Netherlands 5.6% Germany 3.9% United Kingdom 11.1% United States 66.4% Denmark Sweden 2.9% 2.0% Australia 1.4% Norway 1.3% Ireland 1.2% France 1.1% Canada 0.7% EC 0.5% Other Govts 0.7% Italy 0.2% Spain 0.4% $5.9 billion Bilateral Disbursements Japan 0.4% Sources: UNAIDS and Kaiser Family Foundation analysis, July 2010; OECD CRS online data query, June 2010. Notes: Bilateral funding includes HIV-earmarked multilateral funding, but does not include the Global Fund or UNITAID. See Methodology for additional detail. 6

International AIDS Assistance: G8/EC & Other Donor Governments as Share of Global Fund Contributions for AIDS from DAC* Donor Governments, 2009 USD billions France 11.9% United Kingdom 6.5% Germany 10.2% Spain 8.1% Japan 7.3% EC 5.4% Canada 5.3% Sweden 3.4% Netherlands 3.1% $1.6 billion United States 31.7% Italy 0.0% Ireland 0.5% Denmark 1.2% Australia 1.2% Other Govts 1.6% Norway 2.5% Sources: UNAIDS and Kaiser Family Foundation analysis, July 2010; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query, June 2010. Notes: Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). *Members of the OECD s Development Assistance Committee (DAC): www.oecd.org/dac. See Methodology for additional detail. 7

International AIDS Assistance: G8/EC Funding Channels for Disbursements, 2009 23% 10% 11% 12% 13% 16% 20% 32% 39% 41% 42% 66% 74% 80% 84% 86% 77% 100% 90% 89% 88% 87% 84% 80% 68% 61% 59% 58% Global Fund / UNITAID Bilateral 34% 26% 20% 16% 14% Sources: UNAIDS and Kaiser Family Foundation analysis, July 2010; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query, June 2010; UNITAID Annual Report, 2009; OECD CRS online data query, June 2010; UNAIDS, PCB(13)/02.5, 28 November 2002; UNAIDS, PCB(14)/03 Conference Paper 2a, 25 June 2003. Notes: Bilateral funding includes HIV-earmarked multilateral funding; Multilateral funding includes Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV) and UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (49.1% for HIV). See Methodology for additional detail. 8

Resources Available for AIDS from All Sources Compared to UNAIDS Estimate of Resources Needed, 2009 USD billions Gap $7.7 Donor Governments (Bilateral) $10.0 $5.9 All Other (Multilateral, Private, Domestic) $15.9b Available $23.6b Needed Total Estimated Global Resource Needs in Low & Middle Income Countries Sources: UNAIDS and Kaiser Family Foundation analysis, July 2010; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query, June 2010; UNITAID Annual Report, 2009; OECD CRS online data query, June 2010; UNAIDS Estimates, 2010. Notes: Bilateral funding includes HIV-earmarked multilateral funding but does not include the Global Fund or UNITAID; Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (49.1% for HIV). Other financing sources include multilateral, private, and domestic government funding. Resources available are estimated and represent disbursements from all sources. See Methodology for additional detail. 9

Assessing Fair Share 1: Donor Share of World GDP* Compared to Donor Share of All Resources Available for AIDS, 2009 United States Japan Germany France United Kingdom Italy Spain Canada Australia Netherlands Sweden Norway Denmark Ireland 8.7% 0.9% 5.8% 2.4% 4.6% 2.1% 3.8% 4.7% 3.7% 0.1% 2.5% 1.0% 2.3% 0.8% 1.7% 0.6% 1.4% 2.3% 0.7% 1.0% 0.7% 0.8% 0.5% 1.2% 0.4% 0.5% 24.6% 26.9% Share of World GDP Share of All Resources for AIDS Sources: UNAIDS and Kaiser Family Foundation analysis, July 2010; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query, June 2010; UNITAID Annual Report, 2009; International Monetary Fund, World Economic Outlook Database, June 2010. Notes: *GDP = gross domestic product. Bilateral funding includes HIV-earmarked multilateral funding, but does not include the Global Fund or UNITAID; Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (49.1% for HIV). Resources available are estimated and represent disbursements from all sources. See Methodology for additional detail. 10

Assessing Fair Share 2: Donor Rank by Disbursements for AIDS per US$1 Million GDP*, 2009 Denmark Netherlands Sweden United Kingdom Ireland Norway United States France Germany Spain Australia Canada Japan Italy $126.5 $118.7 $111.8 $100.2 $97.2 $28.0 $4.5 $480.6 $423.8 $356.8 $356.7 $339.9 $311.1 $624.9 Sources: UNAIDS and Kaiser Family Foundation analysis, July 2010; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query, June 2010; UNITAID Annual Report, 2009; International Monetary Fund, World Economic Outlook Database, June 2010. Notes: *GDP = gross domestic product. Bilateral funding includes HIV-earmarked multilateral funding, but does not include the Global Fund or UNITAID. Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (49.1% for HIV). See Methodology for additional detail. 11

International AIDS Assistance: G8/EC & Other Donor Governments, Summary Data Table, 2009 USD millions Bilateral Global Fund Government Commitments (Enacted) Disbursements Total (100%) Adjusted (61%) Total (100%) Adjusted (49.1%) Commitments (Enacted) Disbursements Australia $ 79.9 $ 79.9 $ 32.8 $ 20.0 $ 99.9 $ 99.9 Canada $ 43.6 $ 43.6 $ 141.5 $ 86.3 $ 129.9 $ 129.9 Denmark $ 173.8 $ 173.8 $ 31.9 $ 19.5 $ 193.3 $ 193.3 France $ 67.8 $ 67.8 $ 314.8 $ 192.0 $ 160.0 $ 78.6 $ 338.4 $ 338.4 Germany $ 232.3 $ 232.3 $ 271.4 $ 165.6 $ 397.9 $ 397.9 Ireland $ 72.7 $ 72.7 $ 14.0 $ 8.5 $ 81.2 $ 81.2 Italy $ 6.0 $ 9.5 $ 0.0 $ 0.0 $ 6.0 $ 9.5 Japan $ 23.2 $ 23.2 $ 194.4 $ 118.6 $ 141.8 $ 141.8 Netherlands $ 331.0 $ 331.0 $ 83.5 $ 50.9 $ 381.9 $ 381.9 Norway $ 79.3 $ 79.3 $ 67.2 $ 41.0 $ 20.1 $ 9.9 $ 130.2 $ 130.2 Spain $ 22.6 $ 22.6 $ 214.4 $ 130.8 $ 20.9 $ 10.3 $ 163.6 $ 163.6 Sweden $ 117.1 $ 117.1 $ 89.7 $ 54.7 $ 171.8 $ 171.8 United Kingdom $ 653.7 $ 653.7 $ 171.6 $ 104.7 $ 42.1 $ 20.7 $ 779.0 $ 779.0 United States $ 5,035.0 $ 3,921.6 $ 841.4 $ 513.3 $ 5,548.3 $ 4,434.9 European Commission $ 9.8 $ 30.7 $ 143.3 $ 87.4 $ 97.2 $ 118.1 Other DAC Governments $ 50.0 $ 43.1 $ 43.8 $ 26.7 $ 7.1 $ 3.5 $ 80.2 $ 73.3 TOTAL $ 6,997.8 $ 5,901.9 $ 2,655.7 $ 1,620.0 $ 250.2 $ 122.8 $ 8,740.6 $ 7,644.7 G8 Members in Bold. G8 share is 84% of total commitments and 82% of total disbursements. UNITAID Total Sources: UNAIDS and Kaiser Family Foundation analysis, July 2010; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query, June 2010; UNITAID Annual Report, 2009; OECD CRS online data query, June 2010. Notes: Bilateral funding includes HIV-earmarked multilateral funding but does not include the Global Fund or UNITAID. Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (49.1% for HIV). U.S. bilateral commitment data correspond to amounts appropriated by Congress. U.S. Global Fund contributions correspond to amounts received by the Fund during the 2009 calendar year, regardless of which U.S. fiscal year such disbursements pertain to. U.K. and Canadian data are preliminary estimates. With the exception of the U.S., Italy, and the EC, disbursements used as proxy for commitments. Netherlands disbursement data differ from HGIS annual reports, due to exclusion of TB and malaria funding, imputed multilateral funding, and indirect administrative costs. French UNITAID 2009-identified contributions total 141.5 million. Of this, 31.5 million disbursed in 2010 is not reflected above. "Other DAC government" totals represent 2008 data reported to the OECD and by the Global Fund and UNITAID. Japan data represents final 2009 disbursements. See Methodology for additional detail. 12

Annex: Methodology This project represents a collaboration between the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the Kaiser Family Foundation. Data provided in this report were collected and analyzed by UNAIDS and the Kaiser Family Foundation. The Stimson Center conducted research for this project. Bilateral and multilateral data on donor government assistance for AIDS in low- and middle-income countries were collected from multiple sources. The research team solicited bilateral assistance data directly, using uniform protocols, from the governments of Australia, Canada, Denmark, France, Germany, Ireland, Japan, The Netherlands, Norway, Spain, Sweden, The United Kingdom, The United States, and The European Commission during the first half of 2010, representing the fiscal year 2009 period. Direct data collection from these donors was desirable because the latest official statistics on international AIDS specific assistance from the Organisation for Economic Co-operation and Development (OECD) Creditor Reporting System (CRS) (see: http://www.oecd.org/dataoecd/20/29/31753872.htm) are from 2008 and do not include all forms of international assistance (e.g., the CRS no longer collects data on aid to countries and territories in transition, such as those in Central and Eastern Europe and the Newly Independent States of the former Soviet Union). In addition, the CRS data may not include certain funding streams provided by donors, such as HIV components of mixed grants to nongovernmental organizations. The research team therefore undertook direct data collection from the donors who provide significant shares for international AIDS assistance through bilateral channels. Where donor governments were members of the European Union (EU), the research team ensured that no doublecounting of funds occurred between EU Member reported amounts and EC reported amounts for international AIDS assistance. Figures obtained directly using this approach should be considered as the upper bound estimation of financial flows in support of HIV-related activities. Although the Russian Federation is a Member of the G8 and made significant contributions to the Global Fund in 2009, it was a net recipient of AIDS assistance, and therefore is not included in the donor analysis. 13

Methodology continued Data for all other governments Austria, Belgium, Finland, Greece, Luxembourg, New Zealand, Portugal, Switzerland were obtained from the OECD CRS and are from calendar year 2008; these data, therefore, do not necessarily reflect 2009 calendar year amounts. However, collectively, these governments have accounted for less than 5 percent of bilateral commitments and disbursements in each of the past several years. Data included in this report represent funding assistance for HIV prevention, care, treatment and support activities, but do not include funding for international HIV research (which is not considered in estimates of resource needs for service delivery of HIV-related activities). Bilateral funding is defined as any earmarked (HIV-designated) amount, including earmarked contributions to multilateral organizations, such as UNAIDS. In some cases, donors use policy markers to attribute portions of mixed-purpose projects to HIV. This was done by the European Commission, the Netherlands, Denmark, and the UK. U.S. bilateral commitment data correspond to amounts appropriated for the 2009 fiscal year. Global Fund contributions from the U.S. correspond to amounts received by the Fund during the 2009 calendar year, regardless of which contributor s fiscal year such disbursements pertain to. Data from the U.K., Canada, the European Commission, and Japan should be considered preliminary estimates. With the exceptions of the U.S., Italy, Spain, and the European Commission, disbursements were used as a proxy for commitments. Netherlands disbursement data differ from HGIS annual reports, due to exclusion of TB and malaria funding, imputed multilateral funding, and indirect administrative costs. 14

Methodology continued Included in multilateral funding were contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) (see: http://www.theglobalfund.org/en/), and UNITAID (see: http://www.unitaid.eu/). All Global Fund contributions were adjusted to represent 61% of the donor s total contribution, reflecting the Fund s reported grant approvals for HIV-related projects to date. UNITAID contributions were adjusted to represent 49% of the donor s total contribution, reflecting UNITAID s reported funding by disease through the 2009 calendar year. Other than contributions provided by governments to the Global Fund and UNITAID, un-earmarked general contributions to United Nations entities, most of which are membership contributions set by treaty or other formal agreement (e.g., the World Bank s International Development Association or United Nations country membership assessments), are not identified as part of a donor government s AIDS assistance even if the multilateral organization in turn directs some of these funds to AIDS. Rather, these would be considered as AIDS funding provided by the multilateral organization, as in the case of the World Bank s efforts, and are not considered for purposes of this report. Bilateral assistance data were collected for disbursements. A disbursement is the actual release of funds to, or the purchase of goods or services for, a recipient. Disbursements in any given year may include disbursements of funds committed in prior years and in some cases, not all funds committed during a government fiscal year are disbursed in that year. In addition, a disbursement by a government does not necessarily mean that the funds were provided to a country or other intended end-user. Commitments, or obligations, represent firm decisions that funding will be provided, regardless of the time at which actual outlays, or disbursements, occur. In recent years, most governments have ceased use of commitment accounting other than for administrative purposes, have converted to cash accounting frameworks, and accordingly did not provide commitment data for purposes of this report; in such cases, disbursements were used as a proxy for commitments. In the U.S. case, both enacted and disbursement data were available for analysis. 15

Methodology continued Data collected directly from donor governments reflect the fiscal year (FY) period as defined by the donor which varies by country. The U.S. fiscal year runs from October 1-September 30. The Australian fiscal year runs from July 1-June 30. The fiscal years for Canada, Japan, and the U.K. are April 1-March 31. The EC, Denmark, France, Germany, Italy, Ireland, the Netherlands, Norway, Spain, and Sweden use the calendar year. The OECD uses the calendar year, so data collected from the CRS for other donor governments reflect January 1-December 31. Among the key multilateral institutions analyzed, the World Bank fiscal year is July 1-June 30. Most UN agencies use the calendar year and their budgets are biennial. The Global Fund s fiscal year is also the calendar year. All data are expressed in US dollars (USD). Where data were provided by governments in their currencies, they were adjusted by average daily exchange rates to obtain a USD equivalent, based on foreign exchange rate historical data for 2009, available from the U.S. Federal Reserve (see: http://www.federalreserve.gov/). Data obtained from the Global Fund were already adjusted by the Global Fund to represent a USD equivalent. Data on gross domestic product (GDP) were obtained from the International Monetary Fund s World Economic Outlook Database and represent current price data for 2009 (see: http://www.imf.org/external/pubs/ft/weo/2010/01/weodata/index.aspx). 16

UNAIDS, the Joint United Nations Programme on HIV/AIDS, is an innovative United Nations partnership that leads and inspires the world in achieving universal access to HIV prevention, treatment, care and support. Learn more at unaids.org. The Kaiser Family Foundation is a non-profit private operating foundation, based in Menlo Park, California, dedicated to producing and communicating the best possible analysis and information on health issues at www.kff.org This publication (#7347-06) is available on the Kaiser Family Foundation s website at www.kff.org and at the UNAIDS website at www.unaids.org.